纤维蛋白经纤溶切换调控人滋养层生长
该体外研究将玻璃化小鼠与人囊胚置于纤维蛋白基质上培养,发现纤维蛋白不影响小鼠囊胚,但显著抑制人囊胚滋养层生长,随后通过uPA活性增强的纤溶转为促进生长。外源uPA、PAI-1抑制剂或FDPs可促进人滋养层在纤维蛋白存在下的生长。
要点
- 纤维蛋白先抑制人囊胚滋养层生长,纤溶出现后转为促进。
- 人囊胚uPA活性弱于小鼠囊胚,抑制uPA减少滋养层生长。
- 外源uPA、PAI-1抑制剂或FDPs可促进纤维蛋白上人滋养层生长。
核心结论
- 纤维蛋白对人囊胚滋养层生长先抑制后经纤溶转为促进,该现象未见于小鼠囊胚。
研究设计与样本
- 玻璃化小鼠与人囊胚复苏后分别于纤维蛋白基质上体外培养至120 h和168 h,并设非涂层与胶原涂层对照。
主要发现
- 纤维蛋白不影响小鼠囊胚发育速度与形态,附着期可见较大纤维蛋白降解区。
- 纤维蛋白显著抑制人囊胚滋养层向外生长,出现小纤维蛋白降解区后滋养层才生长。
- 条件培养基中uPA为纤溶因子,人囊胚uPA活性显著弱于小鼠囊胚。
- 抑制uPA显著减少小鼠与人囊胚滋养层向外生长。
- 人囊胚表达PLAU、PLAUR、SERPINE1与SERPINB2,小鼠囊胚仅表达Plau、Plaur与Serpine1。
关键数值与推荐
- 外源uPA、PAI-1抑制剂或FDPs均可促进纤维蛋白存在下的人囊胚滋养层生长。
临床怎么用
- 提示胚胎转移培养基添加纤维蛋白对人胚胎的作用可能依赖纤溶表型,需结合uPA活性理解。
局限性
- 该模型排除母体因素,可能无法完全在体内重现。
- 捐赠人胚胎为剩余胚胎,可能本身发育潜能降低。
- ART来源捐赠胚胎可能uPA活性较弱。
- 采用传统培养方法,新培养方案下结果可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does fibrin promote trophoblast growth in human and mouse blastocysts during early embryo implantation? SUMMARY ANSWER: Mouse blastocysts were unaffected by fibrin; however, human blastocysts were significantly suppressed by fibrin in trophoblast growth and then switched to growth promotion through increased fibrinolysis with urokinase-type plasminogen activator (uPA) activity. WHAT IS KNOWN ALREADY: Fibrin(ogen) plays an important role in various physiological processes and is also critical for maintaining feto-maternal attachment during pregnancy. The addition of fibrin to embryo transfer media has been used to increase implantation rates in human ART; however, its mechanism of action' in vitro has not yet been characterized. STUDY DESIGN, SIZE, DURATION: Vitrified mouse and human blastocysts were warmed and individually cultured in vitro for up to 120 and 168 h, respectively, on a fibrin substrate. Blastocysts were cultured at 37°C in 6% CO2, 5% O2 and 89% N2. Blastocyst development and related fibrinolytic factors were analyzed. PARTICIPANTS/MATERIALS, SETTING, METHODS: ICR strain mouse embryos were purchased from a commercial supplier. Human blastocysts were donated with informed consent from two fertility centers. Mouse and human blastocysts cultured on fibrin-coated plates were compared to those on non-coated and collagen-coated plates in vitro. Trophoblast growth and fibrin degradation were assessed based on the cell area and fibrin-free area, respectively. Fibrinolytic factors were detected in supernatants using plasminogen-casein zymography. The fibrinolytic activity of blastocysts was investigated using a selective uPA inhibitor, exogenous uPA, plasminogen activator inhibitor-1 (PAI-1) inhibitor and fibrin degradation products (FDPs). Fibrinolysis-related mRNA expression level was detected using quantitative real-time PCR. MAIN RESULTS AND THE ROLE OF CHANCE: Fibrin did not affect the developmental speed or morphology of mouse blastocysts, and a large fibrin-degrading region was observed in the attachment stage. In contrast, fibrin significantly suppressed the outgrowth of trophoblasts in human blastocysts, and trophoblasts grew after the appearance of small fibrin-degrading regions. uPA was identified as a fibrinolytic factor in the conditioned medium, and uPA activity was significantly weaker in human blastocysts than in mouse blastocysts. The inhibition of uPA significantly reduced the outgrowth of trophoblasts in mouse and human blastocysts. Human blastocysts expressed PLAU (uPA), PLAUR (uPA receptor), SERPINE1 (PAI-1) and SERPINB2 (PAI-2), whereas mouse blastocysts were limited to Plau, Plaur and Serpine1. In a subsequent experiment on human blastocysts, the addition of exogenous uPA and the PAI-1 inhibitor promoted trophoblast growth in the presence of fibrin, as did the addition of FDPs. LIMITATIONS, REASONS FOR CAUTION: This model excludes maternal factors and may not be fully reproduced in vivo. Donated human embryos are surplus embryos that may inherently exhibit reduced embryonic development. In addition, donated ART-derived embryos may exhibit weak uPA activity, because women with sufficient uPA-active embryos may not originally require ART. The present study used orthodox culture methods, and results may change with the application of recently developed protocols for culture blastocysts beyond the implantation stage. WIDER IMPLICATIONS OF THE FINDINGS: The present results suggest that the distinct features of trophoblast outgrowth in human blastocysts observed in the presence of fibrin are regulated by a phenotypic conversion induced by contact with fibrin and FDPs. Mouse embryos did not exhibit the human phenomenon, indicating that the present results may be limited to humans. STUDY FUNDING/COMPETING INTEREST(S): The present study was supported by the Department of Obstetrics and Gynecology at the Hamamatsu University School of Medicine and Kishokai Medical Corporation. None of the authors have any conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Asano Y, Iwaki T, Umemura K, et al. Fibrin-mediated growth restriction of early-stage human trophoblasts is switched to growth promotion through fibrinolysis. Hum Reprod. 2021. PMID: 34597378. doi:10.1093/humrep/deab223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。